Cell cycle-dependent phosphorylation of Disabled-2 by cdc2

Junqi He, Jianguo Xu, Xiangxi Xu, Randy A. Hall

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Disabled-2 (Dab2; also known as p96 and DOC-2) is a signal transduction protein that has been implicated in the control of cell growth. Dab2 is known to be a phosphoprotein, but little is known about the kinases that phosphorylate Dab2. We have found that Dab2 phosphorylation is markedly increased during the mitosis phase of the cell cycle. This phosphorylation is blocked by roscovitine, a selective inhibitor of cyclin-dependent kinases. Dab2 robustly coimmunoprecipitates from cells with the cyclin-dependent kinase cdc2, and purified cdc2 can phosphorylate purified Dab2 fusion proteins in vitro on multiple sites. Cellular phosphorylation of Dab2 by cdc2 promotes the association of Dab2 with Pin1, a peptidylprolyl isomerase that regulates the rate of Dab2 dephosphorylation. These findings reveal that Dab2 is differentially phosphorylated during the cell cycle by cdc2 and provide a potential feedback mechanism by which Dab2 inhibition of cell growth and proliferation may be regulated.

Original languageEnglish
Pages (from-to)4524-4530
Number of pages7
JournalOncogene
Volume22
Issue number29
DOIs
StatePublished - Jul 17 2003
Externally publishedYes

Fingerprint

Cell Cycle
Cyclin-Dependent Kinases
Phosphorylation
Phosphoproteins
Growth
Mitosis
Signal Transduction
Proteins
Phosphotransferases
Cell Proliferation
roscovitine
In Vitro Techniques
NIMA-Interacting Peptidylprolyl Isomerase

Keywords

  • Cancer
  • cdk
  • Kinase
  • Phosphatase
  • Receptor
  • Tumor suppressor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. / He, Junqi; Xu, Jianguo; Xu, Xiangxi; Hall, Randy A.

In: Oncogene, Vol. 22, No. 29, 17.07.2003, p. 4524-4530.

Research output: Contribution to journalArticle

He, Junqi ; Xu, Jianguo ; Xu, Xiangxi ; Hall, Randy A. / Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. In: Oncogene. 2003 ; Vol. 22, No. 29. pp. 4524-4530.
@article{661d3d6109584a2caa9deb482798685d,
title = "Cell cycle-dependent phosphorylation of Disabled-2 by cdc2",
abstract = "Disabled-2 (Dab2; also known as p96 and DOC-2) is a signal transduction protein that has been implicated in the control of cell growth. Dab2 is known to be a phosphoprotein, but little is known about the kinases that phosphorylate Dab2. We have found that Dab2 phosphorylation is markedly increased during the mitosis phase of the cell cycle. This phosphorylation is blocked by roscovitine, a selective inhibitor of cyclin-dependent kinases. Dab2 robustly coimmunoprecipitates from cells with the cyclin-dependent kinase cdc2, and purified cdc2 can phosphorylate purified Dab2 fusion proteins in vitro on multiple sites. Cellular phosphorylation of Dab2 by cdc2 promotes the association of Dab2 with Pin1, a peptidylprolyl isomerase that regulates the rate of Dab2 dephosphorylation. These findings reveal that Dab2 is differentially phosphorylated during the cell cycle by cdc2 and provide a potential feedback mechanism by which Dab2 inhibition of cell growth and proliferation may be regulated.",
keywords = "Cancer, cdk, Kinase, Phosphatase, Receptor, Tumor suppressor",
author = "Junqi He and Jianguo Xu and Xiangxi Xu and Hall, {Randy A.}",
year = "2003",
month = "7",
day = "17",
doi = "10.1038/sj.onc.1206767",
language = "English",
volume = "22",
pages = "4524--4530",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Cell cycle-dependent phosphorylation of Disabled-2 by cdc2

AU - He, Junqi

AU - Xu, Jianguo

AU - Xu, Xiangxi

AU - Hall, Randy A.

PY - 2003/7/17

Y1 - 2003/7/17

N2 - Disabled-2 (Dab2; also known as p96 and DOC-2) is a signal transduction protein that has been implicated in the control of cell growth. Dab2 is known to be a phosphoprotein, but little is known about the kinases that phosphorylate Dab2. We have found that Dab2 phosphorylation is markedly increased during the mitosis phase of the cell cycle. This phosphorylation is blocked by roscovitine, a selective inhibitor of cyclin-dependent kinases. Dab2 robustly coimmunoprecipitates from cells with the cyclin-dependent kinase cdc2, and purified cdc2 can phosphorylate purified Dab2 fusion proteins in vitro on multiple sites. Cellular phosphorylation of Dab2 by cdc2 promotes the association of Dab2 with Pin1, a peptidylprolyl isomerase that regulates the rate of Dab2 dephosphorylation. These findings reveal that Dab2 is differentially phosphorylated during the cell cycle by cdc2 and provide a potential feedback mechanism by which Dab2 inhibition of cell growth and proliferation may be regulated.

AB - Disabled-2 (Dab2; also known as p96 and DOC-2) is a signal transduction protein that has been implicated in the control of cell growth. Dab2 is known to be a phosphoprotein, but little is known about the kinases that phosphorylate Dab2. We have found that Dab2 phosphorylation is markedly increased during the mitosis phase of the cell cycle. This phosphorylation is blocked by roscovitine, a selective inhibitor of cyclin-dependent kinases. Dab2 robustly coimmunoprecipitates from cells with the cyclin-dependent kinase cdc2, and purified cdc2 can phosphorylate purified Dab2 fusion proteins in vitro on multiple sites. Cellular phosphorylation of Dab2 by cdc2 promotes the association of Dab2 with Pin1, a peptidylprolyl isomerase that regulates the rate of Dab2 dephosphorylation. These findings reveal that Dab2 is differentially phosphorylated during the cell cycle by cdc2 and provide a potential feedback mechanism by which Dab2 inhibition of cell growth and proliferation may be regulated.

KW - Cancer

KW - cdk

KW - Kinase

KW - Phosphatase

KW - Receptor

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=0042168729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042168729&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206767

DO - 10.1038/sj.onc.1206767

M3 - Article

C2 - 12881709

AN - SCOPUS:0042168729

VL - 22

SP - 4524

EP - 4530

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -